Concepedia
Statistics
Publications
24
Citations
1.6K
H-Index
22
Active since
1975
Affiliations
Yale University(Current)
National Institutes of Health
University of California, San Francisco
Stanford University
New York University
Paul Berger is an author at Yale University specializing in neuropharmacology, neuroscience, and pharmacology.
Publications per year
1975–2025
Deletion of an N‐terminal regulatory domain of the c‐abl tyrosine kinase activates its oncogenic potential.
Wolfgang-M. Franz, Paul Berger, Jiu‐Yao Wang · The EMBO Journal · 1989 · 207 citations · Full text
Medicine, Molecular Biology, Oncology +13
Characterization of Sodium‐Dependent [<sup>3</sup>H]GBR‐12935 Binding in Brain: A Radioligand for Selective Labelling of the Dopamine Transport Complex
Aaron Janowsky, Paul Berger, Frank J. Vocci et al. · Journal of Neurochemistry · 1986 · 173 citations
Medicine, Neuroscience, Pharmacology +17
Haloperidol prevents induction of the hsp70 heat shock gene in neurons injured by phencyclidine (PCP), MK801, and ketamine
Frank R. Sharp, M. Butman, S. Wang et al. · Journal of Neuroscience Research · 1992 · 107 citations
Pharmacological investigations of the cholinergic imbalance hypotheses of movement disorders and psychosis.
Keith L. Davis, Paul Berger · PubMed · 1978 · 102 citations
Medicine, Neuroscience, Pharmacology +16
[3H]GBR-12935: A specific high affinity ligand for labeling the dopamine transport complex
Paul Berger, Aaron Janowsky, Frank J. Vocci et al. · European Journal of Pharmacology · 1985 · 99 citations
Life Sciences, Neuroscience, Pharmacology +14
1–5 of 24